ARTICLE | Clinical News
HIVIG HIV immune globulin: Beginning Phase III trial
September 27, 1993 7:00 AM UTC
North American Biologicals Inc. (NBIO) Product: HIVIG HIV immune globulin Indication: Prevent HIV transmission from mother to infant Status: Beginning Phase III trial, conducted by the NIH, in 400 pre...